2017 CBA Annual Conference

2017 CBA Annual Conference

 22nd CBA Annual Conference

in collaboration with MedImmune/AstraZeneca

Delivering Lifesaving Medicines to Patients through Innovation, Regulatory Reform and Global Partnership

June 25, 2017 | Gaithersburg, Maryland, USA



(discount rate ends by 11am EST, June 22)

English Meeting Agenda

Chinese Meeting Agenda

Job Positions Open for Recruitment at the Conference

The Chinese Biopharmaceutical Association (CBA-USA), one of the largest Chinese professional associations in the US, is going to collaborate with MedImmune/AstraZeneca to co-host its 22rd annual conference on June 25, 2017 at the beautiful campus and the state-of-art conference facility of MedImmune, a member of the AstraZeneca group, the largest biopharma company in the state of Maryland, in Gaithersburg, Maryland. 

The theme of the 22rd CBA annual conference is “Delivering Lifesaving Medicines to Patients through Innovation, Regulatory Reform and Global Partnership”. The theme has been carefully selected to address the critical importance of worldwide collaboration and partnership to capture the great opportunity for the advancement of innovative medicine and biopharmaceuticals in both USA and China. 

The conference provides a perfect venue for people from government, private agencies, biotech and pharmaceutical companies interested in policy issues, business development, and partnership in US and China. 

In addition to a compelling conference program, CBA will present its 2017 Brilliant Achievement Award at the Conference, recognizing individuals of exemplary accomplishments in promoting collaboration and global development involving the biopharmaceutical sector in China. Also at the Conference, CBA will host the very first US-China Biopharmaceutical Innovation and Enterpreneurship Competition. We anticipate more than 800 attendees for the 2017 Conference.


Distinguished Speakers

Dr. Craig Venter

Co-Founder, Executive Chairman, Head of Scientific Strategy – Human Longevity, Inc. 

Founder, Chairman, and CEO of the J. Craig Venter Institute. 

Dr. Bahija Jallal

Executive Vice President, AstraZeneca and Head of MedImmune

Dr. Robert Temple

Deputy Director of Clinical Science, FDA CDER

Dr. Lawrence Yu

Deputy Director, Office of Pharmaceutical Quality, FDA CDER

Dr. Xinyu Weng

CFDA Liaison in US, First Secrectary of the Chinese Embassy

Dr. Stephen Turner

Co-founder and CTO, Pacific Biosciences

Dr. Guoping Zhao

Executive Director of the Chinese National Human Genome Center at Shanghai 

Dr. Dajun Yang

Chairman of the Board and CEO, Ascentage Pharma, "One Thousand Talent Plan" Scholar

Dr. Yiwu He

Global Head of R&D at BGI, CEO of BGI Groups USA

Dr. Patrick Lu

Chairman of the Board and CEO, Sirnaomics, Inc., "One Thousand Talent Plan" Scholar

Dr. Weiwu He

Chairman of the Board and CEO, Origene, "One Thousand Talent Plan" Scholar

Dr. Dan Zhang

Chairman of the Board and CEO, Fountain Medical Development, "One Thousand Talent Plan" Scholar


Sincere thanks to all the generous sponsors and supporters of the 22nd CBA Annual Conference!